ロード中...

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with DS face various health issues, including learning and memory deficits, congenital heart disease, Alzheimer’s disease (AD), leukemia, and cancer, leading to huge medical and social costs. Remarkable advances...

詳細記述

保存先:
書誌詳細
出版年:Front Behav Neurosci
主要な著者: Duchon, Arnaud, Herault, Yann
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891327/
https://ncbi.nlm.nih.gov/pubmed/27375444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2016.00104
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!